

December 9, 2026 | 5:00-7:00 PM
Ann Arbor
Breakthrough science alone is no longer enough to ensure success. Regulatory uncertainty, shifting policies, capital constraints, and evolving investor expectations are creating new challenges for emerging life science companies.
Join us at BioArbor® on December 9 for a timely fireside conversation featuring Ipsita Smolinski, Managing Director of Capitol Street and faculty member at Georgetown University, moderated by Tony Dace, Vice President – Life Sciences at J.P. Morgan.
Drawing on experience across Wall Street and Washington, the discussion will explore investor priorities, policy shifts, emerging opportunities, and strategies to help life science entrepreneurs navigate an increasingly complex landscape.
REGISTER TODAY |







